Our in vitro and in vivo experiments with Keto, an FDA-approved antifungal drug used as an HK2 inhibitor in glioblastoma, demonstrated that HK2 blockage, in combination with IR, effectively halted cancer cell proliferation and autophagy. Here, HK2 is linked to glioblastoma.